1. Home
  2. ATNM vs LOAN Comparison

ATNM vs LOAN Comparison

Compare ATNM & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.42

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.87

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
LOAN
Founded
2000
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
51.9M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ATNM
LOAN
Price
$1.42
$4.87
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
194.3K
41.3K
Earning Date
11-14-2025
10-24-2025
Dividend Yield
N/A
9.54%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
$90,000.00
$7,138,128.00
Revenue This Year
N/A
N/A
Revenue Next Year
$42,943.57
$4.47
P/E Ratio
N/A
$10.41
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$4.29
52 Week High
$2.41
$6.05

Technical Indicators

Market Signals
Indicator
ATNM
LOAN
Relative Strength Index (RSI) 51.57 55.85
Support Level $1.33 $4.64
Resistance Level $1.54 $4.83
Average True Range (ATR) 0.09 0.14
MACD 0.01 0.05
Stochastic Oscillator 58.86 96.67

Price Performance

Historical Comparison
ATNM
LOAN

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: